Related Experiment Video
Updated: Dec 9, 2025

Purification, Expansion, and Flow Cytometry-Based Phenotyping of Mouse Derived Bone Marrow Mesenchymal Stem Cells
Published on: July 11, 2025
Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells
Maria V Guijarro1,2, Laura S Danielson1, Marta Cañamero3
1Department of Pathology, NYU Grossman School of Medicine, NYU Langone Health, New York, NY 10016, USA.
Abstract:
TSC1 is a tumor suppressor that inhibits cell growth via negative regulation of the mammalian target of rapamycin complex (mTORC1). TSC1 mutations are associated with Tuberous Sclerosis Complex (TSC), characterized by multiple benign tumors of mesenchymal and epithelial origin. TSC1 modulates self-renewal and differentiation in hematopoietic stem cells; however, its effects on mesenchymal stem cells (MSCs) are unknown. We investigated the impact of Tsc1 inactivation in murine bone marrow (BM)-MSCs, using tissue-specific, transgelin (Tagln)-mediated cre-recombination, targeting both BM-MSCs and smooth muscle cells. Tsc1 mutants were viable, but homozygous inactivation led to a dwarfed appearance with TSC-like pathologies in multiple organs and reduced survival. In young (28 day old) mice, Tsc1 deficiency-induced significant cell expansion of non-hematopoietic BM in vivo, and MSC colony-forming potential in vitro, that was normalized upon treatment with the mTOR inhibitor, everolimus. The hyperproliferative BM-MSC phenotype was lost in aged (1.5 yr) mice, and Tsc1 inactivation was also accompanied by elevated ROS and increased senescence. ShRNA-mediated knockdown of Tsc1 in BM-MSCs replicated the hyperproliferative BM-MSC phenotype and led to impaired adipogenic and myogenic differentiation. Our data show that Tsc1 is a negative regulator of BM-MSC proliferation and support a pivotal role for the Tsc1-mTOR axis in the maintenance of the mesenchymal progenitor pool.
Insights
Tuberous Sclerosis Complex 1 (TSC1) loss in mesenchymal stem cells (MSCs) causes overgrowth, which is reversible with mTOR inhibitors. TSC1 loss also impairs MSC differentiation and promotes senescence in aged mice.
Area of Science:
- Cell Biology
- Developmental Biology
- Genetics
Background:
- * Tuberous Sclerosis Complex 1 (TSC1) is a tumor suppressor regulating cell growth through the mammalian target of rapamycin complex 1 (mTORC1).
- * Mutations in TSC1 cause Tuberous Sclerosis Complex (TSC), a disorder marked by benign tumors. TSC1's role in hematopoietic stem cells is known, but its function in mesenchymal stem cells (MSCs) is unclear.
Purpose of the Study:
- * To investigate the role of Tsc1 in the biology of murine bone marrow (BM)-MSCs.
- * To determine the impact of Tsc1 inactivation on MSC proliferation, differentiation, and potential pathologies.
Main Methods:
- * Used tissue-specific cre-recombination (transgelin-mediated) to inactivate Tsc1 in murine BM-MSCs.
- * Analyzed Tsc1 mutant mice for phenotypes, survival, and organ pathologies.
- * Assessed BM-MSC proliferation in vivo and in vitro, including colony-forming potential.
- * Treated mice with the mTOR inhibitor everolimus.
- * Evaluated reactive oxygen species (ROS) and senescence in aged mice.
- * Utilized ShRNA to knock down Tsc1 in BM-MSCs and assessed differentiation capacity.
Main Results:
- * Tsc1 inactivation in BM-MSCs led to dwarfed phenotypes, TSC-like pathologies, and reduced survival.
- * Young Tsc1-deficient mice exhibited significant BM cell expansion and increased MSC colony formation, which normalized with everolimus treatment.
- * Aged Tsc1-deficient mice lost the hyperproliferative phenotype but showed elevated ROS and increased senescence.
- * Tsc1 knockdown in BM-MSCs caused hyperproliferation and impaired adipogenic and myogenic differentiation.
Conclusions:
- * Tsc1 acts as a negative regulator of BM-MSC proliferation.
- * The Tsc1-mTOR axis plays a crucial role in maintaining the mesenchymal progenitor pool.
- * Tsc1 deficiency impacts MSC function, leading to proliferation defects, impaired differentiation, and age-dependent senescence.
Related Concept Videos
Mesenchymal Stem Cells
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
TGF - β Signaling Pathway
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

